Professional Documents
Culture Documents
2011 Resisten Omsk PDF
2011 Resisten Omsk PDF
284
Notes
Table 1. Microbiologic profile of chronic suppurative otitis media Unusually high prevalence of Candida spp. and
Microorganisms isolated No (%) of isolates Aspergillus spp. in this study could be explained
Staphylococcus aureus 26 (30.6) by an excessive and uncontrolled use of antibio-
Pseudomonas aeruginosa 19 (22.4)
tics as it was reported previously (16). There is
Klebsiella spp. 9 (10.6)
Proteus mirabilis 6 (7.1)
also a possibility that in some cases unrecognized
Streptococcus pneumoniae 5 (5.9) fungal inflammations of the auditory canal might
Haemophyllus influenze 3 (3.5) be the cause of the infection, as well as the insu-
Proteus vulgaris 1 (1.2) fficient toilet of the auditory canal (moist, basal
Morganella morganii 1 (l.2) environment in the pretympanal area) (16).
Serretia marcenscens 1 (1.2)
Gram negative bacilli 1 (1.2)
Antibiotic susceptibility testing the isolates obta-
Candida spp. 8 (9.4) ined in this study was in accordance with the re-
Aspergillus spp. 6 (7.1) sults published elsewhere (11, 15).
Saprophitic flora 12 (14.1) In the light of the importance of local therapy in
The analysis by sex and age did not show a pre- the treatment of chronic suppurative inflammati-
dominance of any particular group of patients re- on of the ear, which is the first line of treatment
lated to any aetiological agents. (17,18), and which frequently excludes the need
for systemic therapy (19), it is important to anal-
None of the isolates were resistant to ciprofloxa-
yze the sensitivity of the agent to locally applied
cillin. Staphylococcus aureus showed a marked
therapy. This is especially important because the
sensitivity to gentamycin (88.5%), erythromycin
concentrations of topically administrated antibi-
92.3%), azitromycin (92.3%), sulphometoxasol/
otics can be 100-1000 times greater than those
trimetoprim (92%), and clindamycin (91.7%).
which can be achieved using systemic admini-
Pseudomonas also showed a marked sensitivity
stration (20). Consequently, sensitivity reports by
to third-generation cephalosporins, from 78.6% to
disc-diffusion method from clinical laboratory are
100%, imipenem (91.7%) and piperacillin (75%),
questionable. Sensitivity testing in the clinical la-
and moderate sensitivity to gentamycin (52.6%).
boratory is designed for the tissue concentrations
Streptococcus pneumoniae isolates were sensiti-
achieved by systemic administration. Likewise,
ve to almost all antibiotics tested (Table 2).
one should bear in mind the possibility of oto-
DISCUSSION toxicity which is usually linked to the application
of aminoglycozydes (21, 22), although this was
The results of this study have shown that most never proved beyond doubt.
frequently isolated bacteria were in accordance
Knowing the aetiological agents of chronic suppu-
with findings of other published studies (10, 11).
rative otitis media infection and their susceptibi-
Comparing causative agents of chronic suppura-
lity to antibiotics is of essential importance for an
tive otitis media infections isolated before and
efficient treatment, prevention of both complica-
after the widespread use of antibiotics, usual iso-
tions and development of resistance to antibiotics,
lated pathogens were Streptococcus pneumoniae
avoidance of possible ototoxicity, and finally, the
and Staphylococcus aureus and Pseudomonas
reduction of the treatment costs (23). The aim of
aeruginosa, respectively (12-15).
Table 2. Antibiotic resistence of chronic suppurative otitis media causative agents
Percentage of resistance to antimicrobial agent*
Causative agent AMX AMC CN CXM CAZ CRO CFP IMI PIP GM E AZM CIP CLI SXT
Streptococcus spp. 0 NT NT 0 NT NT NT NT NT NT 20 20 NT 0 0
Proteus spp. 66,7 50 83.3 0 0 0 NT NT NT 50 NT NT 0 NT 20
* AMX, amoksicilin (10µg); AMC, amoksicilin-clavulanate (30µg); CN, cefaleksin (30µg); CXM, cefuroksim (3µg), CAZ, ceftazidim (30µg);
CRO, ceftriakson (30µg); CFP, cefoperazon (30µg); IMI, imipinem (10µg); PIP, piperacilin (100µg); GM, gentamycin (10µg); ERY, erythro-
mycin (15µg); AZM, azitromicin (15µg); CIP, ciprofloksacin (5µg); CLI, clindamycin (2µg); SXT, trimethoprim/sulfamethoxazole, SXT (25 µg);
NT, non test
285
Medicinski Glasnik, Volumen 8, Number 2, August 2011
the conservative therapy is to achieve a “dry ear” 17. Kapusuz Z, Keles E, Alpay HC, Karlidag T, Kay-
for surgical treatment, but it can also represent the gusuz I, Uzunlar AK, Orhan I, Yalcin S. The effect
of topical ciprofloxacin and steroid-containing ear
“final aim” of treatment in non-complicated infla- drops for chronic suppurative otitis media on the in-
mmations in patients who refuse surgery or have ternal ear. Eur Arch Otorhinolaryngol 2010; 267:35-
contraindications for surgery (24). 41.
18. Brook I. Microbiology and menagement of chronic
suppurative otitis media in children. J Trop Pediatr
ACKNOWLEDGMENT/DISCLOSURES 2003; 49:196-200.
Competing interests: none declared. 19. Hannley MT, Denneny JC 3rd, Holzer SS. Use of
ototopical antibiotics in treating three common
ear diseases. Otolaryngol Head Neck Surg 2000;
REFERENCES 122:934-40.
1. Matsuda Y, Kurita T, Ueda Y, Ito S, Nakashima T. 20. Parry D, Roland PS. Middle ear, chronic supurative
Effect of tympanic membrane perforation on midd- otitis, medical treatment. www.emedicine.medsca-
le-ear sound transmission. J Laryngol Otol 2009; pe.com (September 25, 2010)
31:81-9. 21. Chiodo AA, Alberti PW. Experimental, clinical and
2. Wright D, Safranek S. Treatment of otitis media with preventive aspects of ototoxicity. Eur Arch Otorho-
perforated tympanic membrane. Am Fam Physician nolaryngol 1994; 251:375-92.
2009; 79:650-4. 22. Macfadyen CA, Acuin JM, Gamble C. Topical an-
3. van der Veen EL, Schilder AG, van Heerbeek N, tibiotics without steroids for chronically dischar-
Verhoeft M, Zielhius GA, Rovers MM. Predictors ging ears with underlying eardrum perforations.
of chronic suppurative otitis media in children. Arch Cochrane Database of Systematic Reviews 2005;
Otolaryngol Head Neck Surg 2006; 132:1115-8. 4:CD004618.
4. van Hasset P. Chronic suppurative otitis media. 23. Nikakhlagh S, Khosravi AD, Fazlipour M, Safarza-
Comm Ear Hearing H. 2007;4(6):19-21. deh M, Rashidi N. Microbiologic findings in patients
5. Shenoi PM. Menagement of chronic suppurative with chronic suppuratie otitis media. J Medical Sci.
otitis media. In: Kerr AG, Booth JB, editors. Scott- 2008;8:503-506
Brown´s Otoleryngology, 35th ed. London. Bu- 24. Papastavros T, Giamarellou H, Verlejides S. Preope-
tterworth and comp. 1987;215-237. rative therapeutic considerations in chronic suppura-
6. Jahn AF. Chronic otitis media: diagnosis and trea- tive otitis media. Laryngoscope 1989; 99:655-9.
tment. Med Clin North Am 1991; 75:1277-91.
7. Finegold SM, Wexler HM. Therapeutic implications
of bacteriologic findings in mixed aerobic anaero- Mikrobiologija kronične gnojne upale
bic infections. Antimicrob agents chemother 1988;
32:611-16.
srednjeg uha
8. Forbes BA, Sahm DF, Weissfeld AS. Bailey and
Scott´s Diagnostic Microbiology. 12th Edn. St. Branko Krišto, Marko Buljan
Louis: Mosby, 2007: 389-97. Županijska bolnica Livno, Odjel za ORL i cervikofacijalnu kiru-
9. CLSI. Performance standards for antimicrobial sus-
rgiju, Livno, Bosna i Hercegovina
ceptilibity testing. CLSI approved standard M100-
S17. Wayne, PA: CLSI,2007.
10. Smith JA, Danner CJ. Complications of chronic oti-
SAŽETAK
tis media and cholesteatoma. Otolaryngol Clin North
Am 2006; 39:1237-55.
Cilj istraživanja je utvrditi uzročnike kronične
11. Nikakhlag S, Khosravi AD, Fazlipour A, Safarzadeh gnojne upale srednjeg uha i odrediti njihovu
M, Rashidi N. Microbiologic findings in patients osjetljivost na antibiotike, što bi moglo voditi
with chronic suppurative otitis media. J Med Sci boljem liječenju bolesti, a posljedično i izbjega-
2008; 8:503-6. vanju pojave rezistencije na pojedine antibiotike.
12. Sugita R. Bacteriological studies on chronic otitis
media. J Otolaryngol Jpn 1977; 80:907-19.
Najčešće izolirani uzročnici bili su Staphyloco-
13. Brook I, Yocum P. Quantative bacterial cultures and ccus aureus (30.6%), Pseudomonas aeruginosa
beta-lactamase activity in chronic suppurative otitis (22.4%), Klebsiella spp. (10.6%) i Proteus spp.
media. Ann Otol Rhinol Laryngol 1989; 98:293-7. (7.1%). Svi izolirani uzročnici bili su osjetljivi na
14. Nakagawa T, Yadohisa O, Komune S, Kemura T. 16- ciprofloxacin. Izrazitu osjetljivost na gentamycin
year survey of changes in bacterial isolates assotia-
ted with chronic suppurative otitis media. Eur Arch
pokazali su izolati Staphylococcus aureus i Kleb-
Otorhinolaryngol 1994; 251:27-32. siella spp., a umjerenu osjetljivost izolati Pseu-
15. Yeo SG, Park DC, Hong SM, Cha CI, Kim MG. Bac- domonas i Proteus vrsta. Izolati Pseudomonas
teriology of chronic suppurative otitis media- a mul- spp. pokazali su visoku osjetljivost na antibiotike
ticentre study. Acta Otolaryngol 2007; 127:1062-67. treće generacije cefalosporina, kao i na imipenem
16. Hueso Gutierrez P, Jimenez Alvarez S, Gil-Carcedo
Sanudo E, Gil-Carcedo Garcia LM. Ramos Sanchez
i piperacillin.
C, Vallejo Valdezate LA. Presumed diagnosis: oto-
mycosis. A study of 451 patients. Acta Otorrhinola- Ključne riječi: upala srednjeg uha, antimikrobna
ringol Esp 2005; 56:181-86. osjetljivost, antibiotici
286